Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the KRT85 gene cause hair and nail problems.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Prolactin may be important for skin growth and immune function.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Hair loss requires customized treatments based on its various causes and types.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Early diagnosis and treatment of TPP can prevent complications.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.